205 related articles for article (PubMed ID: 8529923)
1. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
Liu L; Wells PG
Free Radic Biol Med; 1995 Nov; 19(5):639-48. PubMed ID: 8529923
[TBL] [Abstract][Full Text] [Related]
2. Oxidative damage in chemical teratogenesis.
Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
[TBL] [Abstract][Full Text] [Related]
3. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
[TBL] [Abstract][Full Text] [Related]
4. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
[TBL] [Abstract][Full Text] [Related]
5. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis.
Winn LM; Wells PG
Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124
[TBL] [Abstract][Full Text] [Related]
6. Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis.
Parman T; Chen G; Wells PG
J Biol Chem; 1998 Sep; 273(39):25079-88. PubMed ID: 9737965
[TBL] [Abstract][Full Text] [Related]
7. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
Winn LM; Wells PG
Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
[TBL] [Abstract][Full Text] [Related]
8. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
Parman T; Wiley MJ; Wells PG
Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
[TBL] [Abstract][Full Text] [Related]
9. Biochemical toxicology of chemical teratogenesis.
Wells PG; Winn LM
Crit Rev Biochem Mol Biol; 1996 Feb; 31(1):1-40. PubMed ID: 8744954
[TBL] [Abstract][Full Text] [Related]
10. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
Yu WK; Wells PG
Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds.
Wells PG; Nagai MK; Greco GS
Toxicol Appl Pharmacol; 1989 Mar; 97(3):406-14. PubMed ID: 2609340
[TBL] [Abstract][Full Text] [Related]
12. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
[TBL] [Abstract][Full Text] [Related]
13. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
Kim PM; Winn LM; Parman T; Wells PG
J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197
[TBL] [Abstract][Full Text] [Related]
14. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
Kubow S; Wells PG
Mol Pharmacol; 1989 Apr; 35(4):504-11. PubMed ID: 2539558
[TBL] [Abstract][Full Text] [Related]
15. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Miranda AF; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phenytoin bioactivation and teratogenicity by dietary n-3 fatty acids in mice.
Kubow S
Lipids; 1992 Sep; 27(9):721-8. PubMed ID: 1487972
[TBL] [Abstract][Full Text] [Related]
17. [Transplacental teratogenesis].
Grella PV
Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():467-72. PubMed ID: 11424790
[TBL] [Abstract][Full Text] [Related]
18. Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice.
Ozolins TR; Siksay DL; Wells PG
J Pharmacol Exp Ther; 1996 May; 277(2):945-53. PubMed ID: 8627577
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and GSH-related enzyme response to a single teratogenic exposure to the anticonvulsant phenytoin: temporospatial evaluation.
Amicarelli F; Tiboni GM; Colafarina S; Bonfigli A; Iammarrone E; Miranda M; Di Ilio C
Teratology; 2000 Aug; 62(2):100-7. PubMed ID: 10931507
[TBL] [Abstract][Full Text] [Related]
20. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
Lee CJ; Gonçalves LL; Wells PG
FASEB J; 2011 Jul; 25(7):2468-83. PubMed ID: 21502285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
